- Home
- KPRX vs LDWY Comparison
KPRX vs LDWY Comparison
Compare KPRX & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- LDWY
- Stock Information
- Founded
- KPRX 1998
- LDWY 1990
- Country
- KPRX United States
- LDWY United States
- Employees
- KPRX N/A
- LDWY N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- LDWY Advertising
- Sector
- KPRX Health Care
- LDWY Consumer Discretionary
- Exchange
- KPRX Nasdaq
- LDWY Nasdaq
- Market Cap
- KPRX 9.2M
- LDWY 9.2M
- IPO Year
- KPRX N/A
- LDWY 1991
- Fundamental
- Price
- KPRX $2.65
- LDWY $5.15
- Analyst Decision
- KPRX Strong Buy
- LDWY
- Analyst Count
- KPRX 1
- LDWY 0
- Target Price
- KPRX $10.00
- LDWY N/A
- AVG Volume (30 Days)
- KPRX 32.4K
- LDWY 5.7K
- Earning Date
- KPRX 11-07-2025
- LDWY 08-28-2025
- Dividend Yield
- KPRX N/A
- LDWY N/A
- EPS Growth
- KPRX N/A
- LDWY N/A
- EPS
- KPRX N/A
- LDWY 1.66
- Revenue
- KPRX N/A
- LDWY $71,244,000.00
- Revenue This Year
- KPRX N/A
- LDWY N/A
- Revenue Next Year
- KPRX N/A
- LDWY N/A
- P/E Ratio
- KPRX N/A
- LDWY $3.18
- Revenue Growth
- KPRX N/A
- LDWY 187.12
- 52 Week Low
- KPRX $2.25
- LDWY $3.02
- 52 Week High
- KPRX $4.18
- LDWY $6.19
- Technical
- Relative Strength Index (RSI)
- KPRX 46.53
- LDWY 50.99
- Support Level
- KPRX $2.60
- LDWY N/A
- Resistance Level
- KPRX $2.80
- LDWY $5.35
- Average True Range (ATR)
- KPRX 0.11
- LDWY 0.29
- MACD
- KPRX -0.01
- LDWY -0.25
- Stochastic Oscillator
- KPRX 21.21
- LDWY 83.20
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.